Optimizing Fall-risk Prediction in Older Adults With Cancer

Completed

Conditions studied: Cancer

In brief

To establish the optimal strategy of fall-risk assessment to predict falls in older adults receiving cancer therapy.

Key facts

Study ID

NCT02912273

Run by

Washington University School of Medicine

People needed

227

Starts

2016-10-12

Expected to finish

2020-01-09

Last updated by the study team

2020-10-14

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥65
• Receiving systemic cancer therapy, including conventional chemotherapy, novel/targeted agents or hormonal agents (e.g. anti-estrogen or anti-androgen) OR will begin systemic therapy within the next 4 weeks.
• Estimated life expectancy >1 year
• Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites
• Able to understand and willing to sign an IRB-approved written informed consent document

You may not qualify if…

• Unable to read and understand English

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.